Clinical Trial

COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
A phase 1, dose-finding open label clinical infection, safety and viral detection optimization in healthy volunteers immunologically experienced against SARS-CoV-2.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-06-26; most recent amendment 2026-04-23.
Status change: Enrolling by Invitation → Active, Not Recruiting 2026-04-23
Status change: Recruiting → Enrolling by Invitation 2024-09-06
Trial Details
NCT Number NCT06478420
Lead Sponsor University of Oxford
Collaborators: Imperial College Healthcare NHS Trust, Chelsea and Westminster NHS Foundation Trust, Royal Free London NHS Trust
Conditions SARS-CoV-2 Infection
Enrollment 45 participants
Start Date 2024-08-08
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24